Predicting dopamine agonist resistance in patients with macroprolactinoma is essential for
clinicians to prevent treatment failure and subsequent complications such as medication …

Los prolactinomas son el tipo más frecuente de los tumores hipofisarios secretores en la
población adulta. La presentación clínica de esta patología es variable y puede cursar con …

Los prolactinomas son el tipo más frecuente de los tumores hipofisarios secretores en la
población adulta. La presentación clínica de esta patología es variable y puede cursar con …

Introduction: prolactinomas account for half of the etiological causes of presentation
adenomas in the pediatric population, hence their important role as differential diagnosis in …

Cerebrospinal fluid (CSF) leak is a rare complication in of the prolactinomas treatment with
dopamine agonists. In most cases CSF leak develops within the first three months of …

Objective: Data on whether there is a histopathological difference in cellular features as
determined with Ki-67 between giant prolactinomas and smaller macroprolactinomas are …

Introduction Pons herniation after cabergoline therapy for giant prolactinoma is a
complication not documented in literature. Case report We report a medium aged patient …

Prolactin-secreting adenomas are the most common pituitary tumors and a common cause
of pathological hyperprolactinemia. Prolactinomas are classified according to their size …

Prolactinomas having the diameter above 4 cm are termed 'giant prolactinomas'. 1 2 Their
incidence is approximately 2%–3% of all prolactinomas 1. These are associated with very …